News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
657,438 Results
Type
Article (31425)
Company Profile (169)
Press Release (625888)
Multimedia
Podcasts (44)
Webinars (10)
Section
Business (209777)
Career Advice (702)
Deals (31406)
Drug Delivery (69)
Drug Development (72479)
Employer Resources (53)
FDA (15292)
Job Trends (12819)
News (311187)
Policy (28919)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (1965)
Accelerated approval (38)
ADA (39)
Adcomms (12)
Allergies (177)
Alliances (44192)
ALS (180)
Alzheimer's disease (1550)
Antibody-drug conjugate (ADC) (402)
Approvals (15996)
Artificial intelligence (551)
ASCO (267)
Autoimmune disease (301)
Automation (36)
Bankruptcy (319)
Best Places to Work (10171)
BIO (52)
BIOSECURE Act (6)
Biosimilars (167)
Biotechnology (105)
Bladder cancer (197)
Brain cancer (60)
Breast cancer (731)
Cancer (5471)
Cardiovascular disease (409)
Career advice (611)
Career pathing (18)
CAR-T (270)
CDC (36)
Celiac Disease (3)
Cell therapy (717)
Cervical cancer (53)
Clinical research (65056)
Collaboration (1786)
Commercialization (2)
Company closure (1)
Compensation (1433)
Complete response letters (51)
COVID-19 (1863)
CRISPR (88)
C-suite (1057)
Cystic fibrosis (126)
Data (7925)
Decentralized trials (2)
Denatured (24)
Depression (155)
Dermatology (94)
Diabetes (574)
Diagnostics (5965)
Digital health (54)
Diversity (8)
Diversity, equity & inclusion (17)
Drug discovery (227)
Drug pricing (156)
Drug shortages (24)
Duchenne muscular dystrophy (234)
Earnings (83813)
Editorial (41)
Employer branding (6)
Employer resources (54)
Events (109928)
Executive appointments (980)
FDA (19177)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (21)
Frontotemporal dementia (28)
Funding (1430)
Gene editing (174)
Generative AI (32)
Gene therapy (511)
GLP-1 (754)
Government (3555)
Grass and pollen (4)
Guidances (386)
Healthcare (16708)
Hematology (154)
HIV (75)
Huntington's disease (44)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (90)
Immunology and inflammation (160)
Immuno-oncology (83)
Indications (209)
Infectious disease (2151)
Inflammatory bowel disease (201)
Inflation Reduction Act (13)
Influenza (117)
Intellectual property (292)
Interviews (80)
IPO (14641)
IRA (41)
Job creations (3053)
Job search strategy (563)
JPM (19)
Kidney cancer (21)
Labor market (51)
Layoffs (242)
Leadership (11)
Legal (7137)
Liver cancer (83)
Longevity (25)
Lung cancer (770)
Lymphoma (419)
Machine learning (43)
Management (19)
Manufacturing (757)
Marketing (9)
MASH (171)
Medical affairs (1)
Medical device (14397)
Medtech (14598)
Mergers & acquisitions (17995)
Metabolic disorders (1282)
mRNA (125)
Multiple sclerosis (172)
NASH (12)
Neurodegenerative disease (343)
Neuropsychiatric disorders (70)
Neuroscience (2877)
NextGen: Class of 2026 (5481)
Non-profit (3294)
Now hiring (43)
Obesity (504)
Opinion (132)
Ovarian cancer (218)
Pain (255)
Pancreatic cancer (293)
Parkinson's disease (320)
Partnered (26)
Patents (561)
Patient recruitment (752)
Peanut (58)
People (54876)
Pharmaceutical (40)
Pharmacy benefit managers (23)
Phase 1 (20184)
Phase 2 (28569)
Phase 3 (21055)
Pipeline (9129)
Policy (186)
Postmarket research (2390)
Preclinical (8143)
Press Release (46)
Prostate cancer (304)
Psychedelics (34)
Radiopharmaceuticals (298)
Rare diseases (889)
Real estate (4687)
Recruiting (21)
Regulatory (23286)
Reports (25)
Research institute (1936)
Resumes & cover letters (89)
Rett syndrome (43)
RNA editing (12)
RSV (67)
Schizophrenia (160)
Series A (232)
Series B (182)
Service/supplier (5)
Sickle cell disease (96)
Special edition (8)
Spinal muscular atrophy (144)
Sponsored (20)
Startups (3101)
Stomach cancer (14)
Supply chain (90)
Tariffs (38)
The Weekly (20)
Vaccines (741)
Venture capital (46)
Weight loss (311)
Women's health (119)
Worklife (4)
Date
Today (72)
Last 7 days (341)
Last 30 days (1619)
Last 365 days (25954)
2026 (14762)
2025 (26046)
2024 (30758)
2023 (35200)
2022 (45658)
2021 (49466)
2020 (47606)
2019 (39025)
2018 (29427)
2017 (27589)
2016 (27067)
2015 (33409)
2014 (28523)
2013 (24205)
2012 (26508)
2011 (26904)
2010 (26034)
Location
Africa (514)
Alabama (85)
Alaska (4)
Arizona (357)
Arkansas (16)
Asia (33861)
Australia (5125)
California (13185)
Canada (3594)
China (1262)
Colorado (594)
Connecticut (546)
Delaware (385)
Europe (63597)
Florida (2007)
Georgia (433)
Hawaii (2)
Idaho (56)
Illinois (1109)
India (64)
Indiana (543)
Iowa (17)
Japan (545)
Kansas (124)
Kentucky (39)
Louisiana (49)
Maine (32)
Maryland (1592)
Massachusetts (9109)
Michigan (367)
Minnesota (739)
Mississippi (7)
Missouri (128)
Montana (28)
Nebraska (26)
Nevada (135)
New Hampshire (80)
New Jersey (3467)
New Mexico (19)
New York (3400)
North Carolina (1653)
North Dakota (7)
Northern California (6578)
Ohio (364)
Oklahoma (19)
Oregon (34)
Pennsylvania (2570)
Puerto Rico (26)
Rhode Island (47)
South America (762)
South Carolina (85)
South Dakota (1)
Southern California (5391)
Tennessee (213)
Texas (2170)
United States (46060)
Utah (399)
Vermont (1)
Virginia (280)
Washington D.C. (68)
Washington State (1068)
West Virginia (4)
Wisconsin (121)
Wyoming (1)
657,438 Results for "monteris medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Monteris Medical Secures $28 Million in Growth Equity to Accelerate Revenue and Innovation in Minimally Invasive Neurosurgery
March 13, 2026
·
3 min read
Press Releases
Monteris Medical Announces New Study Showing NeuroBlate® Laser Ablation May Enhance Immunotherapy Response, Providing Significant Overall Survival Improvement in Recurrent High Grade Brain Tumors
March 4, 2026
·
3 min read
Press Releases
Monteris Medical Announces Largest Prospective Publication to Date in JAMA Neurology on LITT for Epilepsy Cohort Using the NeuroBlate® System
July 16, 2025
·
4 min read
BioMidwest
Monteris Medical Announces Publication of Largest Cohort to Date of LITT with NeuroBlate® System for Meningioma, Most Common Primary Brain Tumor
Monteris Medical announced today that a study on laser interstitial thermal therapy (LITT) for patients with meningioma, the most commonly diagnosed primary brain tumor, was published in the March 8 issue of Journal of Neurosurgery.
April 3, 2024
·
3 min read
BioMidwest
Monteris Medical Announces Extended Aetna® Coverage of its NeuroBlate® System Laser Interstitial Thermal Therapy for Brain Tumor Patients
Monteris Medical, the leader in minimally invasive image-guided laser interstitial thermal therapy (LITT), announced today that health insurance provider Aetna has updated its medical policy and will provide coverage to its beneficiaries with recurrent brain metastases, radiation necrosis and recurrent glioblastoma.
November 8, 2023
·
3 min read
Press Releases
Belmont Medical Completes Acquisition of Arcos, Inc.
June 17, 2026
·
4 min read
Press Releases
Mercury Medical Awarded Respiratory Therapy, Resuscitation Devices Agreement with Premier, Inc.
July 22, 2026
·
2 min read
Press Releases
Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders’ Equity Requirement
July 20, 2026
·
4 min read
Press Releases
Novanta Inc. Announces Acquisition of Riverpoint Medical
June 9, 2026
·
12 min read
Press Releases
Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering
July 1, 2026
·
6 min read
1 of 65,744
Next
